Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

NCT02309385 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Non-Infectious Anterior Uveitis

Interventions

DRUG: 8% Dexamethasone Sodium Phosphate - Visulex
DRUG: 15% Dexamethasone Sodium Phosphate - Visulex
DRUG: Prednisolone Acetate (1%) Eye Drops

Sponsor

Aciont Inc

Collaborators

[object Object]